Macquarie Group LTD Ardelyx, Inc. Transaction History
Macquarie Group LTD
- $80.3 Billion
- Q1 2025
A detailed history of Macquarie Group LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 11,158,139 shares of ARDX stock, worth $44.2 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
11,158,139
Previous 10,346,592
7.84%
Holding current value
$44.2 Million
Previous $53.5 Million
2.42%
% of portfolio
0.07%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding ARDX
# of Institutions
235Shares Held
166MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$98.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$69.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$59.4 Million0.0% of portfolio
-
State Street Corp Boston, MA10.2MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X08.38MShares$33.2 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $612M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...